NBIX
Neurocrine Biosciences Inc.
$125
Earnings Summary
Revenue | $622.1Mn |
Net Profits | $129.8Mn |
Net Profit Margins | 20.86% |
Highlights
Neurocrine Biosciences Inc.’s revenue jumped 24.72% since last year same period to $622.1Mn in the Q3 2024. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 5.4% jump in its revenue since last 3-months.
Neurocrine Biosciences Inc.’s net profit jumped 56.2% since last year same period to $129.8Mn in the Q3 2024. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 99.69% jump in its net profits since last 3-months.
Neurocrine Biosciences Inc.’s net profit margin jumped 25.24% since last year same period to 20.86% in the Q3 2024. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 89.45% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Neurocrine Biosciences Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 1.51 |
EPS Estimate Current Year | 1.51 |
Highlights
Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.51 - a 43.81% jump from last quarter’s estimates.
Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.51.
Key Ratios
Key ratios of the Neurocrine Biosciences Inc. post its Q3 2024 earnings
Earning Per Share (EPS) | 1.24 |
Highlights
Neurocrine Biosciences Inc.’s earning per share (EPS) jumped 51.22% since last year same period to 1.24 in the Q3 2024. This indicates that the Neurocrine Biosciences Inc. has generated 51.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-01 | 1.05 | 0.63 | -40% |
2024-10-30 | 1.51 | 1.24 | -17.88% |
2024-05-01 | 1.01 | 0.42 | -58.42% |
₹0 US Stocks a/c Opening Fee